发明名称 NITROGENATED HETEROCYCLIC COMPOUND
摘要 <p>The present invention provides a compound having a PDE2A selective inhibitory action, which is useful as an agent for the prophylaxis or treatment of schizophrenia, Alzheimer's disease and the like. The present invention is a compound represented by the formula (1): wherein each symbol is as described in the specification, or a salt thereof.</p>
申请公布号 HK1203500(A1) 申请公布日期 2015.10.30
申请号 HK20150104072 申请日期 2015.04.28
申请人 TAKEDA PHARMACEUTICAL COMPANY LIMITED 发明人 MIKAMI, SATOSHI;NAKAMURA, SHINJI;ASHIZAWA, TOMOKO;SASAKI, SHIGEKAZU;TANIGUCHI, TAKAHIKO;NOMURA, IZUMI;KAWASAKI, MASANORI
分类号 C07D;A61K;A61P 主分类号 C07D
代理机构 代理人
主权项
地址